AT
AZN icon

American Trust’s AstraZeneca AZN Stock Holding History

American Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$209K Sell
1,103
-30
-3% -$5.64K 0.02% 317
2026
Q1 		$223K Sell
1,133
-19
-2% -$3.66K 0.02% 287
2025
Q4 		$212K Buy
+1,152
New +$202K 0.02% 305
2025
Q1 		– Sell
-2,030
Closed -$266K – 138
2024
Q4 		$266K Sell
2,030
-21
-1% -$2.94K 0.02% 247
2024
Q3 		$320K Sell
2,051
-143
-7% -$23.1K 0.03% 176
2024
Q2 		$342K Buy
2,194
+479
+28% +$72.1K 0.03% 156
2024
Q1 		$232K Sell
1,715
-518
-23% -$68.6K 0.02% 239
2023
Q4 		$301K Buy
2,233
+73
+3% +$9.49K 0.02% 207
2023
Q3 		$293K Sell
2,160
-350
-14% -$47.8K 0.02% 213
2023
Q2 		$359K Sell
2,510
-70
-3% -$10.3K 0.02% 263
2023
Q1 		$358K Sell
2,580
-268
-9% -$36.1K 0.02% 269
2022
Q4 		$386K Buy
+2,848
New +$357K 0.04% 265

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

American Trust's AZN Position: Q2 2026 in Review

American Trust reduced its AstraZeneca (AZN) stake by 2.6% in Q2 2026, selling an estimated $5.64K and leaving 1,103 shares worth $209K. The position accounts for 0.02% of the portfolio, ranked #317.

American Trust first reported a position in AZN in Q4 2022 and has held it in 12 quarters since. The position peaked at $386K in Q4 2022. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • American Trust held 1,103 shares of AstraZeneca worth $209K as of Q2 2026.
  • American Trust sold 30 AstraZeneca shares in Q2 2026, an estimated $5.64K.
  • AstraZeneca made up 0.02% of American Trust's portfolio in Q2 2026, its #317 holding.
  • American Trust first reported a position in AstraZeneca in Q4 2022 and has held it in 12 quarters since.
  • American Trust's AstraZeneca position peaked at $386K in Q4 2022.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on American Trust's 13F filing for Q2 2026, filed 14 Aug 2026.